TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/23/2025
Back to search
Official data from USPTO
EXPEDIEN RX PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXPEDIEN RX PHARMACY
ST13
US500000086080869Class
35
Filing
86080869
Registration
4886334
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
09/28/2025
Trademark type
Word
Nice classes
35
Filing date
10/02/2013
Registration date
01/12/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/16/2025
Last transaction
09/28/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/01/2015
First use in commerce
10/01/2015
Drawing code
4
Owner type
03
Owner location
Atlamonte Springs, FL
Examiner
HWANG,JOHN C B
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Adventist Health System/Sunbelt, Inc.
Representatives
BRYAN P. STANLEY KUTAK ROCK LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Mail order and internet retail pharmacy services
Publications
History of USPTO decisions and trademark events.
46 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/23/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/23/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/16/2025
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/16/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/16/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/15/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
02/13/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/12/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/23/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/23/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/23/2022
E815
TEAS SECTION 8 & 15 RECEIVED
12/02/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/12/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/12/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/09/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/08/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/07/2015
IUAF
USE AMENDMENT FILED
11/19/2015
EISU
TEAS STATEMENT OF USE RECEIVED
11/19/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/16/2015
EX2G
SOU EXTENSION 2 GRANTED
05/15/2015
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/15/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/15/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/23/2015
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/14/2015
EXT2
SOU EXTENSION 2 FILED
04/03/2015
EEXT
SOU TEAS EXTENSION RECEIVED
04/03/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/14/2014
EX1G
SOU EXTENSION 1 GRANTED
11/12/2014
EXT1
SOU EXTENSION 1 FILED
11/12/2014
EEXT
SOU TEAS EXTENSION RECEIVED
11/12/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/20/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/25/2014
PUBO
PUBLISHED FOR OPPOSITION
03/25/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/18/2014
ALIE
ASSIGNED TO LIE
02/10/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/21/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
01/21/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/21/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
01/21/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/21/2014
DOCK
ASSIGNED TO EXAMINER
01/15/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/09/2013
NWAP
NEW APPLICATION ENTERED
10/05/2013
Continuous trademark protection
Get notified about every new filing that threatens EXPEDIEN RX PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.